ISPO

Novel Therapies III

Therapeutic exploitation of (proto)oncogenes as inducers of tumor angiogenesis

J Rak PhD, RS Kerbel PhD

Molecular screening for colorectal cancer

JS Mandel PhD MPH

Reversal of drug resistance

PH Wiernik MD, E Paietta PhD

Treating human myelogenous leukemia with c-myb antisense oligodeoxynucleotides: two years clinical experience

AM Gewirtz, S Luger, D Sokol, B Gowdin, E Stadtmauer, A Reccio, MZ Ratajczak

Molecular genetics of lymphoid neoplasms

U Jaeger MD

Choice of gene therapy vectors

RJ Cristiano PhD, JA Roth MD